These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 6323780)

  • 1. [Effects of 8-benzylthio-N6-n-butyl-adenosine-3',5'-monophosphate on cardiovascular system. 1. Cardiac output and myocardial contraction].
    Kotaki M
    Masui; 1983 Nov; 32(11):1340-6. PubMed ID: 6323780
    [No Abstract]   [Full Text] [Related]  

  • 2. Stimulation of myocardial contractility by a new cyclic nucleotide analog, 8-(benzylthio)-N6-n-butyladenosine cyclic 3',5'-phosphate (SQ 80122).
    Evans DB; Parham CS; Schenck MT; Laffan RJ
    J Cyclic Nucleotide Res; 1976 Jul-AUG; 2(4):307-19. PubMed ID: 184129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac and metabolic effects of dibutyryl cyclic AMP in the intact dog heart and the isolated perfused rat heart.
    Dhalla NS; Chernecki W; Gandhi SS; McNamara DB; Naimark A
    Recent Adv Stud Cardiac Struct Metab; 1973; 3():233-50. PubMed ID: 4377597
    [No Abstract]   [Full Text] [Related]  

  • 4. Hemodynamic effects of BTB-cyclic AMP in anesthetized dogs.
    Imura K; Ogawa K; Ito T; Satake T
    Jpn Heart J; 1986 Sep; 27(5):741-7. PubMed ID: 3029452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular effects of orciprenaline (Alupent) inhalation and prednisolone.
    Prasad K; Szabo L
    Adv Myocardiol; 1980; 1():437-52. PubMed ID: 7394342
    [No Abstract]   [Full Text] [Related]  

  • 6. [Cardiovascular effects of the slow intravenous infusion of verapamil].
    de Moura RS
    Arq Bras Cardiol; 1982 Feb; 38(2):111-4. PubMed ID: 7159243
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of dibutyryl cyclic AMP on myocardial performance in vivo.
    Cutilletta AF; Lin CY; Thilenius OG; Arcilla RA
    Recent Adv Stud Cardiac Struct Metab; 1973; 3():251-9. PubMed ID: 4377598
    [No Abstract]   [Full Text] [Related]  

  • 8. Mechanisms and quantitative assessment of drug effects on cardiac output with a new model of the circulation.
    Greenway CV
    Pharmacol Rev; 1981 Dec; 33(4):213-51. PubMed ID: 7041140
    [No Abstract]   [Full Text] [Related]  

  • 9. A role for glucagon in cardiac therapy.
    Parmley WW; Sonnenblick EH
    Am J Med Sci; 1969 Oct; 258(4):224-9. PubMed ID: 4309903
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effects of CO2 on the cardiovascular system].
    Foex P
    Anesth Analg (Paris); 1978; 35(5):721-35. PubMed ID: 747228
    [No Abstract]   [Full Text] [Related]  

  • 11. In vivo and in vitro assessment of the cardiovascular effects of 8-(benzylthio)-N6-n-butyl-cyclic AMP.
    Nakazawa M; Takeda K; Nakagawa Y; Tamatsu H; Matsui K; Nakahara H; Kimura T; Kawada T; Imai S
    J Cardiovasc Pharmacol; 1985; 7(5):862-8. PubMed ID: 2413293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on the cardiovascular effects of synthetic vasopressin.
    Nakano J
    J Pharmacol Exp Ther; 1967 Jul; 157(1):19-31. PubMed ID: 6029485
    [No Abstract]   [Full Text] [Related]  

  • 13. [Hemodynamic effects of contrast media. I. Response in normal subjects].
    Chioin R; Scognamiglio R; Stritoni P; Razzolini R; Congedo E; Corbara F; Boffa GM; Fusaro A
    G Clin Med; 1980 Oct; 61(10):759-68. PubMed ID: 7239051
    [No Abstract]   [Full Text] [Related]  

  • 14. [Continuous assessment of angiographic contrast media effects on myocardial function in dogs (author's transl)].
    Di Donato M; Bongrani S; Cucchini F; Ferrari R; Fappani A; Visioli O
    G Ital Cardiol; 1978; 8(3):283-91. PubMed ID: 346429
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of Immobilon and Revivon on the cardiovascular system and acid base status of the Göttingen minipig.
    Becker M; Beglinger R
    Res Vet Sci; 1980 Jul; 29(1):21-5. PubMed ID: 7455349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hemodynamic effects of contrast media. II. Response in patients with coronary disease].
    Scognamiglio R; Chioin R; Razzolini R; Stritoni P; Daliento L; Ramondo A; Dalla Volta S; Fusaro A
    G Clin Med; 1980 Oct; 61(10):769-75. PubMed ID: 7239052
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of CGS 21680, a selective A2A adenosine receptor agonist, on cardiac output and vascular resistance in acute heart failure in the anaesthetized rat.
    Nekooeian AA; Tabrizchi R
    Br J Pharmacol; 1998 Apr; 123(8):1666-72. PubMed ID: 9605574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differentiation of the cardiovascular effects of CI-581.
    Traber DL; Wilson RD; Priano LL
    Anesth Analg; 1968; 47(6):769-78. PubMed ID: 5749340
    [No Abstract]   [Full Text] [Related]  

  • 19. Synthesis and enzymatic and inotropic activity of some new 8-substituted and 6,8-disubstituted derivatives of adenosine cyclic 3',5'-monophosphate.
    Miller JP; Boswell KH; Meyer RB; Christensen LF; Robins RK
    J Med Chem; 1980 Mar; 23(3):242-51. PubMed ID: 6245211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The effects of non-depolarizing neuromuscular blocking agents on the cardiac contractility and cardiovascular system (author's transl)].
    Matsukawa S
    Masui; 1980 Jul; 29(7):648-56. PubMed ID: 7411843
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.